In a phase 2 study, Ojemda (tovorafenib) led to responses in 43% of adults with melanoma or other solid tumors that carried rare RAF gene changes. Ojemda (tovorafenib) shrank tumors in 10 of 23 adults ...

Moderna (MRNA) stock surged 14% after reports of a new NIH cancer research initiative and encouraging trial data with Merck.

A three-drug combination helped treatment-resistant melanoma respond again to immune-based therapy in mouse experiments. The ...

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the developer of cancer immunotherapies, is pressing ahead with plans ...

The INMC analysis links pathological response after neoadjuvant immunotherapy with long-term outcomes in melanoma and ...

Of course, that’s the natural reaction to seeing these super close-up photos of skin lesions, but taking a good look may just ...

Doctors in Illinois and Michigan detailed a 46-year-old man with a previous history of skin cancer who bought the peptide Melanotan-II to help with his tanning. Five weeks after he started using the ...

Alex Shved took the province to court after OHIP rejected his oncologist's request to receive urgent treatment in the U.S.

The trip of a lifetime to the US to watch basketball has turned into a fight for life for a young Melbourne man after a ...

Volunteer Intake Remains Open as the Company Prepares to Post Updated Evaluation Results on Its Corporate Website in ...

Melanoma detection is rising, but mortality isn't. Are we catching more dangerous cancers or overlabeling harmless lesions?